CSI Market
Sign In | Register

Nutralife Biosciences (NTFL) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access NTFL quarterly Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Nutralife Biosciences's cash-generating activities.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2021)
12 Months 		(Dec 31 2020) (Dec 31 2020) (Dec 31 2018) (Dec 31 2017)
Operating Activities
Income-5.83
Depreciation & amortization0.05
Amortization of Other Assets0.50
Increase (Decrease) in Deferred Revenue0.07
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.26
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation2.57
Income (Loss) from Equity Method Investments0.00
Debt Instrument, Convertible, Beneficial Conversion Feature0.00
Reclassification Of Down Payment For Equipment-
Stock Issued During Period Shares Issued For Services Related Party-
Stock Issued During Period Value Issued For Services-
Accumulated Depreciation Depletion And Amortization Reclassifications Of Property Plant And Equipment-
Income From Indebtedness-
Bad Debt Expense-
Gain On Settlement Of Payable-
Accumulated Depreciation Depletion And Amortization Reclassifications From Property Plant And Equipment-
Amortization Of Stock Based Comepensation-
Loss On Settlement Of Accounts Payable-
Stock Compensation And Consulting Services-
Stock Issued In Connection With Finance Costs-
Amortization Of Prepaid Compensation-
Operating Lease Right Of Use Asset Amortization Expense0.21
Warrants Issued In Connection With Debt Conversion-0.49
Income From Debt Forgiveness-0.22
Increase Decrease In Operating Lease Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.11
Increase (Decrease) in Accounts Payable0.11
Increase (Decrease) in Accrued Liabilities0.30
Increase (Decrease) in Customer Deposits0.00
Increase (Decrease) in Prepaid Expense0.03
Other Working Capital0.03
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities2.54
Discontinued operations0.00
Net Cash flow from Operating Activities-0.49
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-0.68
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.68
Financing Activities
Short-term debt Net0.24
Other borrowing transactions0.00
Long-term debt - borrowings0.73
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.35
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Stock Issued-
Interest Expense Borrowings-
Interest Expense Other Short Term Borrowings-
Issuance Of Convertible Debt-
Debt Issuance Costs-
Proceeds From Issuance Of Debt Related Party-
Finance Lease Principal Payments-0.02
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations0.00
Proceeds From Revenue Share Agreements-
Payments On Revenue Share Agreements-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.30
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.49
Total Cash Flow0.14
4 historic quarters locked

Sign in to unlock the full Nutralife Biosciences cash flow history.

Sign In Create Free Account

About Nutralife Biosciences Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-22-033121

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License